Abstract
BackgroundDonor-specific blood transfusion (DST) prior to solid organ transplantation has been shown to induce long-term allograft survival in the absence of immunosuppressive therapy. Although the mechanisms underlying DST-induced allograft tolerance are not well defined, there is evidence to suggest DST induces one or more populations of antigen-specific regulatory cells that suppress allograft rejection. However, neither the identity nor the regulatory properties of these tolerogenic lymphocytes have been reported. Therefore, the objective of this study was to define the kinetics, phenotype and suppressive function of the regulatory cells induced by DST alone or in combination with liver allograft transplantation (LTx).Methodology/Principal FindingsTolerance to Dark Agouti (DA; RT1a) rat liver allografts was induced by injection (iv) of 1 ml of heparinized DA blood to naïve Lewis (LEW; RT1l) rats once per week for 4 weeks prior to LTx. We found that preoperative DST alone generates CD4+ T-cells that when transferred into naïve LEW recipients are capable of suppressing DA liver allograft rejection and promoting long-term survival of the graft and recipient. However, these DST-generated T-cells did not express the regulatory T-cell (Treg) transcription factor Foxp3 nor did they suppress alloantigen (DA)-induced activation of LEW T-cells in vitro suggesting that these lymphocytes are not fully functional regulatory Tregs. We did observe that DST+LTx (but not DST alone) induced the time-dependent formation of CD4+Foxp3+ Tregs that potently suppressed alloantigen-induced activation of naïve LEW T-cells in vitro and liver allograft rejection in vivo. Finally, we present data demonstrating that virtually all of the Foxp3-expressing Tregs reside within the CD4+CD45RC− population whereas in which approximately 50% of these Tregs express CD25.Conclusions/SignificanceWe conclude that preoperative DST, in the absence of liver allograft transplantation, induces the formation of CD4+ T-cells that are not themselves Tregs but give rise directly or indirectly to fully functional CD4+CD45RC−Foxp3+Tregs when transferred into MHC mismatched recipients prior to LTx. These Tregs possess potent suppressive activity and are capable of suppressing acute liver allograft rejection. Understanding the mechanisms by which preoperative DST induces the generation of tolerogenic Tregs in the presence of alloantigens may lead to the development of novel antigen-specific immunological therapies for the treatment of solid organ rejection.
Highlights
Transplantation of different organs across major histocompatability complex (MHC) barriers induces potent effector responses by the immune system resulting in the substantial tissue injury and rejection of the allograft
Donor-specific blood transfusion (DST) has been shown to induce immune hyporesponsiveness and tolerance to a number of different tissues including heart, kidney and liver in the absence of exogenous immunosuppressive agents[5,6,7,8,9,10,11,12]. It is known for example, that DST significantly prolongs heart or liver allograft survival mononuclear/lymphocyte cell infiltration into DST-treated allografts was found to be as great when compared to untreated grafts in early phase following transplantation[13,14].These data suggested that deletion of alloreactive T-cells may not be the mechanism by which allografts are protected from acute rejection
Data presented in the current study demonstrate the novel finding that adoptive transfer of DST-primed CD4+ T-cells suppresses liver allograft rejection despite the fact that these Tcells express little or no Foxp3 and possess no Mixed Lymphocyte Reaction (MLR) suppressive activity in vitro
Summary
Transplantation of different organs across major histocompatability complex (MHC) barriers induces potent effector responses by the immune system resulting in the substantial tissue injury and rejection of the allograft. Donor-specific blood transfusion (DST) has been shown to induce immune hyporesponsiveness and tolerance to a number of different tissues including heart, kidney and liver in the absence of exogenous immunosuppressive agents[5,6,7,8,9,10,11,12] It is known for example, that DST significantly prolongs heart or liver allograft survival mononuclear/lymphocyte cell infiltration into DST-treated allografts was found to be as great (or greater) when compared to untreated grafts in early phase following transplantation[13,14].These data suggested that deletion of alloreactive T-cells may not be the mechanism by which allografts are protected from acute rejection. The objective of this study was to define the kinetics, phenotype and suppressive function of the regulatory cells induced by DST alone or in combination with liver allograft transplantation (LTx)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.